Enovis Corporation

medical technology company

Based in DE

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $350K in lobbying spend across 8 quarterly filings, Enovis Corporation is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2024.

$350K
Total Spend
3
Years Active
1
Firms Hired
9
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$100K
2023$200K
2024$50K

Issues Lobbied

Health Issues

Lobbying Firms

Brownstein Hyatt Farber Schreck, LLP

Lobbyists

Zachary PfisterSohil KhuranaAdam SteinmetzNadeam ElshamiEmily FelderLaura BollierLakeitha AndersonDeema TaraziGregory Sunstrum

Government Agencies Targeted

These are the government entities that Enovis Corporation disclosed contacting in their lobbying filings.

Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues

Durable medical equipment coverage and reimbursement Prior authorization

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

State of Loc Nation Global Public Benefit Corporation
$160.0M total spend
W.l. Gore & Associates
$6.5M total spend
Guarding Against Pandemics, INC.
$2.0M total spend
Nrx Pharmaceuticals INC (Formerly Known as Neurorx)
$754K total spend
Astrazeneca Pharmaceuticals LP
$530K total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.